N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide
C23H25BrN4O4S — CID 98306060
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide
N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide (PubChem CID 98306060) has the molecular formula C23H25BrN4O4S and a molecular weight of 533.45 g/mol. Its IUPAC name is N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide.
Molecular Properties
| Compound Name | N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide |
|---|---|
| PubChem CID | 98306060 |
| Molecular Formula | C23H25BrN4O4S |
| Molecular Weight | 533.45 g/mol |
| Exact Mass | 532.08 |
| IUPAC Name | N-[(2R,3S)-1-[[5-(3-bromophenyl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2,4-dimethoxybenzamide |
| SMILES | CC[C@H](C)[C@@H](NC(=O)c1ccc(OC)cc1OC)C(=O)Nc1nnc(-c2cccc(Br)c2)s1 |
| InChI | InChI=1S/C23H25BrN4O4S/c1-5-13(2)19(25-20(29)17-10-9-16(31-3)12-18(17)32-4)21(30)26-23-28-27-22(33-23)14-7-6-8-15(24)11-14/h6-13,19H,5H2,1-4H3,(H,25,29)(H,26,28,30)/t13-,19+/m0/s1 |
| InChIKey | DSAXVVFTRFCSHG-ORAYPTAESA-N |
| XLogP | 4.77 |
| TPSA | 102.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 533.45 |
| LogP ≤ 5 | 4.77 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 98306060 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.